Characterization of IG-MYC-breakpoints and their application for quantitative minimal disease monitoring in high-risk pediatric Burkitt-lymphoma and -leukemia
1 Pediatric Hematology and Oncology and NHL-BFM Study Center, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.
2 Pediatric Hematology and Oncology and CoALL Study Center, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.
3 Department of Pediatric Hematology and Oncology, Hannover Medical School, and NHL-BFM Study Center, Hannover, Germany.
4 Bioinformatics Core, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.
5 Pediatric Hematology and Oncology and NHL-BFM study Center, University Hospital Muenster, Muenster, Germany.
6 Mildred Scheel Cancer Career Center HaTriCS4, University Medical Center Hamburg- Eppendorf, Hamburg, Germany.
7 Department of Pathology, Hematopathology Section and Lymph Node Registry, University Hospital Schleswig-Holstein, Campus Kiel/Christian-Albrechts-University, Kiel, Germany.
8 Department of Pathology, Justus-Liebig-University, Giessen, Germany.
9 Pediatric Hematology and Oncology and NHL-BFM Study Center, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany. w.woessmann@uke.de.
10 Pediatric Hematology and Oncology and NHL-BFM Study Center, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany. c.damm-welk@uke.de.